Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Marchant

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell Research|January 22, 2024
CCHFV entry via LDLR keeps it 'ticking'?Ahmed K Oraby, David J Marchant
Pharmacology & Therapeutics|March 25, 2016
Emerging pharmacologic targets and treatments for myocarditisLionel D Jensen, David J Marchant
Circulation|June 10, 2010
Regulating viral myocarditis: allografted regulatory T cells decrease immune infiltration and viral loadDavid J Marchant, Bruce M McManus
Clinical Microbiology Reviews|December 2, 2016
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and TreatmentCameron Griffiths, Steven J Drews, David J Marchant
Frontiers in Cellular and Infection Microbiology|October 29, 2021
Imaging Flow Cytometry and Confocal Immunofluorescence Microscopy of Virus-Host Cell InteractionsRyley D McClelland, Tyce N Culp, David J Marchant
Journal of Cardiovascular Translational Research|January 2, 2014
Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditisReid G Hendry, Leanne M Bilawchuk, David J Marchant
Methods in Enzymology|December 24, 2013
Virus-induced signaling influences endosome trafficking, virus entry, and replicationDavid J Marchant, Leanne Bilawchuk, Gordon Nish, et al.
Annual Review of Pathology|October 16, 2025
Molecular Mechanisms of Respiratory Syncytial Virus PathogenesisMadison J Granoski, Aleksandra Stojic, Stephen Z Lee, et al.
ACS Omega|May 27, 2024
Structure-Based Discovery of Allosteric Inhibitors Targeting a New Druggable Site in the Respiratory Syncytial Virus PolymeraseAhmed K Oraby, Leanne Bilawchuk, Frederick G West, et al.
Viruses|August 4, 2017
The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization are Dependent upon the Method of Virus PurificationLeanne M Bilawchuk, Cameron D Griffiths, Lionel D Jensen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Research|January 22, 2024
CCHFV entry via LDLR keeps it 'ticking'?Ahmed K Oraby, David J Marchant
Pharmacology & Therapeutics|March 25, 2016
Emerging pharmacologic targets and treatments for myocarditisLionel D Jensen, David J Marchant
Circulation|June 10, 2010
Regulating viral myocarditis: allografted regulatory T cells decrease immune infiltration and viral loadDavid J Marchant, Bruce M McManus
Clinical Microbiology Reviews|December 2, 2016
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and TreatmentCameron Griffiths, Steven J Drews, David J Marchant
Frontiers in Cellular and Infection Microbiology|October 29, 2021
Imaging Flow Cytometry and Confocal Immunofluorescence Microscopy of Virus-Host Cell InteractionsRyley D McClelland, Tyce N Culp, David J Marchant
Journal of Cardiovascular Translational Research|January 2, 2014
Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditisReid G Hendry, Leanne M Bilawchuk, David J Marchant
Methods in Enzymology|December 24, 2013
Virus-induced signaling influences endosome trafficking, virus entry, and replicationDavid J Marchant, Leanne Bilawchuk, Gordon Nish, et al.
Annual Review of Pathology|October 16, 2025
Molecular Mechanisms of Respiratory Syncytial Virus PathogenesisMadison J Granoski, Aleksandra Stojic, Stephen Z Lee, et al.
ACS Omega|May 27, 2024
Structure-Based Discovery of Allosteric Inhibitors Targeting a New Druggable Site in the Respiratory Syncytial Virus PolymeraseAhmed K Oraby, Leanne Bilawchuk, Frederick G West, et al.
Viruses|August 4, 2017
The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization are Dependent upon the Method of Virus PurificationLeanne M Bilawchuk, Cameron D Griffiths, Lionel D Jensen, et al.
Pageof 3